Compounds > clopidogrel

clopidogrel and Cirrhosis

clopidogrel has been researched along with Cirrhosis in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (18.18)29.6817
2010's8 (72.73)24.3611
2020's1 (9.09)2.80

Authors

AuthorsStudies
Chen, J; Huang, XR; Lan, HY; Tang, PM; Tang, Y; Wei, B; Xu, A; Zhong, Y1
Badimon, L; Ben-Aicha, S; Capdevila, A; Carlsson, L; Carreras, F; Casani, L; Gutiérrez, M; Hidalgo, A; Lambert, C; Mendieta, G; Pons-Lladó, G; Vilahur, G1
Cai, L; Cheng, Y; Fu, Y; Gao, J; Gozal, E; Lian, X; Lu, X; Ma, T; Rane, MJ; Sun, W; Wang, W; Weng, W; Zheng, Z1
Cui, W; Du, J; Jia, LX; Li, TT; Liu, O; Qi, GM; Qi, YF; Yang, M; Zhang, WM1
Du, XJ; Kiriazis, H1
Birnbaum, GD; Birnbaum, Y; Nanhwan, MK; Nylander, S; Perez-Polo, JR; Ye, Y1
Brodie, BR; Duffy, PL; Inaba, S; Kirtane, AJ; Maehara, A; Mazzaferri, EL; Metzger, DC; Mintz, GS; Rinaldi, MJ; Shimizu, T; Stone, GW; Stuckey, TD; Weisz, G; Witzenbichler, B; Yun, KH1
Li, YH; Wu, HM; Xu, Y; Yang, J; Yang, LH; Yue-Meng, W1
Afek, A; George, J; Keren, G; Kogan, E; Maysel-Auslender, S; Mor, A; Regev, E; Rubinstein, A1
Abegunewardene, N; Gori, T; Horstick, G; Kreitner, KF; Lehr, HA; Münzel, T; Schmidt, KH; Schreiber, LM; Vosseler, M1
Albertson, CM; Fink, LM; Hauer-Jensen, M; Herbert, JM; Wang, J; Zheng, H1

Other Studies

11 other study(ies) available for clopidogrel and Cirrhosis

ArticleYear
P2Y12 inhibitor clopidogrel inhibits renal fibrosis by blocking macrophage-to-myofibroblast transition.
    Molecular therapy : the journal of the American Society of Gene Therapy, 2022, 09-07, Volume: 30, Issue:9

    Topics: Animals; Clopidogrel; Fibrosis; Kidney; Kidney Diseases; Macrophages; Mice; Mice, Inbred C57BL; Myofibroblasts; Renal Insufficiency, Chronic; Signal Transduction; Smad3 Protein; Transforming Growth Factor beta; Transforming Growth Factor beta1; Ureteral Obstruction

2022
P2Y12 antagonists and cardiac repair post-myocardial infarction: global and regional heart function analysis and molecular assessments in pigs.
    Cardiovascular research, 2018, 12-01, Volume: 114, Issue:14

    Topics: AMP-Activated Protein Kinases; Animals; Clopidogrel; Disease Models, Animal; Echocardiography; Fibrosis; Heart Ventricles; Magnetic Resonance Imaging, Cine; Myocardial Infarction; Myocytes, Cardiac; Proto-Oncogene Proteins c-akt; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Signal Transduction; Stroke Volume; Sus scrofa; Ticagrelor; Time Factors; Ventricular Function, Left; Ventricular Remodeling

2018
Clopidogrel Reduces Fibronectin Accumulation and Improves Diabetes-Induced Renal Fibrosis.
    International journal of biological sciences, 2019, Volume: 15, Issue:1

    Topics: Animals; Blood Coagulation; Blotting, Western; Clopidogrel; Diabetes Mellitus, Experimental; Fibronectins; Fibrosis; Immunohistochemistry; Kidney; Kidney Diseases; Male; Mice; Mice, Inbred C57BL; Purinergic P2Y Receptor Antagonists

2019
Inhibition of platelet activation by clopidogrel prevents hypertension-induced cardiac inflammation and fibrosis.
    Cardiovascular drugs and therapy, 2013, Volume: 27, Issue:6

    Topics: Angiotensin II; Animals; Clopidogrel; Fibrosis; Hypertension; Interleukin-1beta; Male; Mice; Mice, Inbred C57BL; Myocarditis; Myocardium; Platelet Activation; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Ticlopidine; Transforming Growth Factor beta

2013
Pro-inflammatory role of platelets in hypertension-mediated end-organ damage : Editorial to: "Inhibition of Platelet activation by clopidogrel prevents hypertension-induced cardiac inflammation and fibrosis" by L.-X. Jia et al.
    Cardiovascular drugs and therapy, 2013, Volume: 27, Issue:6

    Topics: Animals; Clopidogrel; Fibrosis; Hypertension; Male; Myocarditis; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Ticlopidine

2013
Ticagrelor protects the heart against reperfusion injury and improves remodeling after myocardial infarction.
    Arteriosclerosis, thrombosis, and vascular biology, 2015, Volume: 35, Issue:8

    Topics: Adenosine; Administration, Oral; Animals; Apoptosis; Cardiotonic Agents; Clopidogrel; Disease Models, Animal; Dose-Response Relationship, Drug; Fibrosis; Injections, Intraperitoneal; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Purinergic P2Y Receptor Antagonists; Rats, Sprague-Dawley; Signal Transduction; Ticagrelor; Ticlopidine; Time Factors; Ventricular Function, Left; Ventricular Remodeling

2015
Relationship Between Platelet Reactivity and Culprit Lesion Morphology: An Assessment From the ADAPT-DES Intravascular Ultrasound Substudy.
    JACC. Cardiovascular imaging, 2016, Volume: 9, Issue:7

    Topics: Aged; Chi-Square Distribution; Clopidogrel; Coronary Artery Disease; Coronary Vessels; Drug Resistance; Drug-Eluting Stents; Female; Fibrosis; Germany; Humans; Least-Squares Analysis; Logistic Models; Male; Middle Aged; Multivariate Analysis; Percutaneous Coronary Intervention; Plaque, Atherosclerotic; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Predictive Value of Tests; Prospective Studies; Risk Factors; Ticlopidine; Time Factors; Treatment Outcome; Ultrasonography, Interventional; United States

2016
Portal Vein Thrombosis in Patients With Cirrhosis Undergoing Elective Transjugular Intrahepatic Portosystemic Shunt: Risk Factors, Warfarin Efficacy, and Clinical Outcomes.
    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2018, Volume: 24, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Aspirin; Clopidogrel; Elective Surgical Procedures; Female; Fibrosis; Humans; Male; Middle Aged; Portal Vein; Portasystemic Shunt, Transjugular Intrahepatic; Risk Factors; Ticlopidine; Treatment Outcome; Venous Thrombosis; Warfarin

2018
Clopidogrel attenuates atheroma formation and induces a stable plaque phenotype in apolipoprotein E knockout mice.
    Microvascular research, 2009, Volume: 77, Issue:3

    Topics: Animals; Apolipoproteins E; Atherosclerosis; Cell Proliferation; Cells, Cultured; Clopidogrel; Disease Models, Animal; Endothelium, Vascular; Female; Fibrosis; Mice; Mice, Inbred C57BL; Mice, Knockout; Platelet Aggregation Inhibitors; Sinus of Valsalva; Spleen; Stem Cells; T-Lymphocytes, Regulatory; Ticlopidine

2009
Gene therapy with iNOS enhances regional contractility and reduces delayed contrast enhancement in a model of postischemic congestive heart failure.
    Clinical hemorheology and microcirculation, 2011, Volume: 49, Issue:1-4

    Topics: Animals; Anticoagulants; Aspirin; Clopidogrel; Contrast Media; Coronary Angiography; Coronary Stenosis; Disease Models, Animal; Drug Carriers; Female; Fibrosis; Gadolinium; Genes, Reporter; Genes, Synthetic; Genetic Therapy; Heart Failure; Liposomes; Magnetic Resonance Imaging; Male; Myocardial Contraction; Myocardial Ischemia; Nitric Oxide Synthase Type II; Random Allocation; Stents; Sus scrofa; Swine; Ticlopidine; Ventricular Dysfunction, Left

2011
Short-term inhibition of ADP-induced platelet aggregation by clopidogrel ameliorates radiation-induced toxicity in rat small intestine.
    Thrombosis and haemostasis, 2002, Volume: 87, Issue:1

    Topics: Adenosine Diphosphate; Animals; Chemotaxis, Leukocyte; Clopidogrel; Collagen; Endothelium, Vascular; Enteritis; Extracellular Matrix; Fibrosis; Gastrointestinal Hemorrhage; Intestine, Small; Male; Muscle, Smooth; Neutrophils; Platelet Aggregation; Platelet Aggregation Inhibitors; Radiation Injuries, Experimental; Rats; Rats, Sprague-Dawley; RNA, Messenger; Ticlopidine; Time Factors; Transforming Growth Factor beta; Transforming Growth Factor beta1

2002